Viatris (VTRS) Change in Taxes (2020 - 2026)
Viatris (VTRS) posted Change in Taxes of $40.9 million for Q2 2026, up 108.83% on a QoQ basis from -$463.4 million in Q1 2026, and up 116.63% year-over-year from $18.9 million in Q2 2025.
Analysis
Viatris (VTRS) Change in Taxes (2020 - 2026) Analysis & Trends
Viatris has reported Change in Taxes for 7 years, with the latest figure at $40.9 million in Q2 2026.
- On a quarterly basis, Change in Taxes rose 116.63% year-over-year to $40.9 million in Q2 2026; TTM through Jun 2026 was -$168.8 million, a 1.69% decrease from a year earlier, with the FY2025 full-year figure at -$112.9 million, down 151.48% from the prior year.
- Change in Taxes was $40.9 million for Q2 2026 at Viatris, up from -$463.4 million in the prior quarter.
- The five-year high for Change in Taxes was $268.2 million in Q3 2024, with the low at -$463.4 million in Q1 2026.
- Average Change in Taxes over 5 years is -$20.4 million, with a median of -$3.2 million recorded in 2022.
- The sharpest annual moves came in 2024 and 2025: Change in Taxes jumped 3676.0% in 2024, then plunged 5143.48% in 2025.
- Over 5 years, Change in Taxes stood at -$4.2 million in 2022, then tumbled by 1021.43% to -$47.1 million in 2023, then slumped by 43.52% to -$67.6 million in 2024, then surged by 285.65% to $125.5 million in 2025, then slumped by 67.41% to $40.9 million in 2026.
- The last three Change in Taxes figures came in at $40.9 million (Q2 2026), -$463.4 million (Q1 2026), and $125.5 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.63 Bn | 38.97 Bn | 2.15 Bn | - |
| 2 | Viatris | 19.19 Bn | 18.30 Bn | 1.46 Bn | 40.90 Mn |
| 3 | Dr Reddys Laboratories | 9.86 Bn | 9.69 Bn | 396.53 Mn | -20.51 Mn |
| 4 | Amneal Pharmaceuticals | 5.48 Bn | 5.35 Bn | 334.51 Mn | - |
| 5 | Bausch Health Companies | 2.36 Bn | 520.30 Mn | 2.10 Bn | - |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | -208,000.00 |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | -1.77 Mn |
| 8 | Amphastar Pharmaceuticals | 995.52 Mn | 705.40 Mn | 93.47 Mn | - |
| 9 | Fennec Pharmaceuticals | 404.35 Mn | 363.10 Mn | 17.15 Mn | - |
| 10 | RedHill Biopharma | 176.59 Mn | 176.59 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 40.90 Mn |
| Mar 31, 2026 | -463.40 Mn |
| Dec 31, 2025 | 125.50 Mn |
| Sep 30, 2025 | 128.20 Mn |
| Jun 30, 2025 | -246.00 Mn |
| Mar 31, 2025 | -120.60 Mn |
| Dec 31, 2024 | -67.60 Mn |
| Sep 30, 2024 | 268.20 Mn |
| Jun 30, 2024 | 21.00 Mn |
| Mar 31, 2024 | -2.30 Mn |
| Dec 31, 2023 | -47.10 Mn |
| Sep 30, 2023 | -7.50 Mn |
| Jun 30, 2023 | 31.80 Mn |
| Mar 31, 2023 | -53.90 Mn |
| Dec 31, 2022 | -4.20 Mn |
| Sep 30, 2022 | 11.70 Mn |
| Jun 30, 2022 | -49.20 Mn |
| Mar 31, 2022 | 67.00 Mn |
| Dec 31, 2021 | -24.30 Mn |
| Sep 30, 2021 | -337.60 Mn |